Trademark: 90109938
Word
ONCXERNA THERAPEUTICS
Status Date
Thursday, September 14, 2023
Filing Date
Wednesday, August 12, 2020
Published for Opposition
Tuesday, July 20, 2021
5 Pharmaceutical preparations, namely, preparations containing proteins for the treatment and diagnosis of cancer, viral infections and infectious diseases; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic biomarker reagents for medical purposes; diagnostic agents for medical use, namely, tumor markers; antigens for medical purposes; diagnostic reagents for medical use; diagnostic agents for pharmaceutical use
1 Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, cultures of microorganisms, protein-based capsids and particles as well as fragments, fractions and derivatives thereof, for scientific and medical research; chemicals for use in biotechnological product development; active chemical ingredients for use in the manufacture of anti-cancer drugs; protein arrays for diagnosing cancer
42 Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; bioinformatics, chemical and biological analysis
ON CXERNA THERAPEUTICS
"THERAPEUTICS"
Sep 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 14, 2023
Sou Extension 4 Granted
Sep 14, 2023
Sou Extension 4 Filed
Sep 14, 2023
Sou Teas Extension Received
Feb 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 22, 2023
Sou Extension 3 Granted
Feb 22, 2023
Sou Extension 3 Filed
Feb 22, 2023
Sou Teas Extension Received
Sep 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 7, 2022
Sou Extension 2 Granted
Sep 7, 2022
Sou Extension 2 Filed
Sep 7, 2022
Sou Teas Extension Received
Jan 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 27, 2022
Sou Extension 1 Granted
Jan 27, 2022
Sou Extension 1 Filed
Jan 27, 2022
Sou Teas Extension Received
Sep 14, 2021
Noa E-Mailed - Sou Required From Applicant
Jul 20, 2021
Official Gazette Publication Confirmation E-Mailed
Jul 20, 2021
Published For Opposition
Jun 30, 2021
Notification Of Notice Of Publication E-Mailed
Jun 12, 2021
Approved For Pub - Principal Register
Jun 10, 2021
Teas/Email Correspondence Entered
Jun 10, 2021
Correspondence Received In Law Office
Jun 10, 2021
Teas Response To Office Action Received
Dec 10, 2020
Notification Of Non-Final Action E-Mailed
Dec 10, 2020
Non-Final Action E-Mailed
Dec 10, 2020
Non-Final Action Written
Dec 7, 2020
Assigned To Examiner
Oct 15, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 15, 2020
Teas Change Of Correspondence Received
Oct 15, 2020
Teas Change Of Owner Address Received
Sep 24, 2020
Automatic Update Of Assignment Of Ownership
Sep 15, 2020
New Application Office Supplied Data Entered
Aug 15, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
